Stock listing

ALBPS Stock Price, News, Filings & Events — Biophytis Sa

Selected listing: ALBPS · EURONEXT · EUR · FR

This page tracks Biophytis Sa's ALBPS:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALBPS:EURONEXT. ALBPS:EURONEXT is the stock-level entry point for investors researching Biophytis Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biophytis SA is a public company traded on the French market under the ticker ALBPS. The company has a market capitalization of approximately €2.1 million. Biophytis focuses on developing innovative therapies for age-related diseases and conditions.

ALBPS:EURONEXTEURFRUpdated September 12, 2026
Biophytis Sa logo
Ticker
ALBPS:EURONEXT
Asset type
Stock
Market cap
$17.6M
Sector
Health Technology
Industry
Pharmaceuticals: Other
Exchange
EURONEXT
Currency
EUR

Biophytis Sa ALBPS:EURONEXT stock context

This page tracks Biophytis Sa's ALBPS:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALBPS:EURONEXT. ALBPS:EURONEXT is the stock-level entry point for investors researching Biophytis Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biophytis SA is a public company traded on the French market under the ticker ALBPS. The company has a market capitalization of approximately €2.1 million. Biophytis focuses on developing innovative therapies for age-related diseases and conditions.

Latest news from Biophytis Sa

All Biophytis Sa news →

Research Biophytis Sa

Alternate listings